Article Details
Retrieved on: 2020-12-22 13:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Other programs in development for atopic dermatitis include KIND-032, a fully caninized monoclonal antibody targeting IL-4R. A second pilot study to ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here